Fetuin A Association in Periodontal Disease and Diabetes Mellitus
Evaluation of Fetuin-A and hsCRP Levels in Gingival Crevicular Fluid in Periodontitis Diabetic and Non-Diabetic Patients
1 other identifier
observational
45
1 country
1
Brief Summary
Aim: The aim of the current study was to compare and correlate gingival crevicular fluid (GCF) fetuin-A levels and high sensitivity C-reactive protein (hs-CRP) levels in non-diabetic periodontitis patients and type 2 diabetic periodontitis patients with healthy subjects and revealing its possible role in diagnosis of periodontal disease. Methodology: Forty-five periodontitis stage III patients categorized into 3 groups according to whether having type II diabetes mellitus or not were compared to systemically and periodontally healthy participants in this investigation. Clinical parameters for all groups were recorded. Assessment of GCF levels of fetuin A and hs-CRP were done to all enrolled participants utilizing an enzyme linked immune-sorbent assay (ELISA) kit. Receiver operating characteristic (ROC) curve was performed to reveal sensitivity, specificity, predictive value and diagnostic accuracy of the markers used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2023
CompletedFirst Submitted
Initial submission to the registry
September 20, 2023
CompletedFirst Posted
Study publicly available on registry
October 3, 2023
CompletedOctober 3, 2023
September 1, 2023
2 months
September 20, 2023
September 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
GCF levels of fetuin A and hsCRP evaluation in all groups
ELIZA kits
levels of fetuin A and hsCRP are measured at baseline after the completion of all GCF sample collection carried at the day of enrollment of subjects in the investigation after diagnosis confirmation
Study Arms (3)
Group I
15 healthy patients with generalized periodontitis stage III.
Group II
15 patients suffering from type 2 diabetes mellitus with generalized periodontitis stage III
Group III
15 systemically healthy patients without periodontitis
Interventions
ELIZA kits are used for GCF levels of fetuin A and hsCRP evaluation
Eligibility Criteria
individuals recruited from outpatient clinic of periodontology department
You may qualify if:
- both gender periodontitis stage III
You may not qualify if:
- Smoking,
- Systemic diseases (except DM in group B),
- Periodontitis patients having periodontal treatment recently (past 6 months),
- Pregnancy, lactation, contraceptive pills,
- Anti-inflammatory/ immunosuppressive drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
faculty of dentistry, Fayoum university
Al Fayyum, Egypt
Biospecimen
GCF samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
September 20, 2023
First Posted
October 3, 2023
Study Start
August 1, 2023
Primary Completion
September 15, 2023
Study Completion
September 15, 2023
Last Updated
October 3, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share